PURPOSE: Bladder cancer is a common malignancy often diagnosed in older adults. Previous studies have reported racial/ethnic disparities in bladder cancer survival outcomes but have not focused on younger patients. We identified whether factors influencing cause specific survival in adolescents and young adults (ages 15 to 39) differed from older adults, and defined prognostic factors specifically in adolescents and young adults using the California Cancer Registry. MATERIALS AND METHODS: Patients diagnosed with bladder cancer between 1988 through 2012 were included in the study. The primary outcome measure was cause specific survival. A multivariable Cox proportional hazards regression model was used to evaluate predictors of cause specific survival in patients of all ages and in adolescents/young adults. Interactions of age and other variables between younger and older adult patients were assessed. RESULTS: Of 104,974 patients with bladder cancer we identified 1,688 adolescent and young adult patients (1.6%). Compared to older patients these patients had a 58% reduced risk of bladder cancer death (HR 0.42, p <0.001). Significant age interactions were identified involving race/ethnicity and histology. Among adolescents and young adults, nonHispanic African-American patients with low socioeconomic status had poor cause specific (HR 7.1, p <0.001) and overall (HR 5.02, p <0.001) survival. CONCLUSIONS: Racial/ethnic and socioeconomic disparities exist in adolescent and young adult patients with bladder cancer in California. Further studies are warranted to identify the underlying causes in order to overcome these disparities.
PURPOSE:Bladder cancer is a common malignancy often diagnosed in older adults. Previous studies have reported racial/ethnic disparities in bladder cancer survival outcomes but have not focused on younger patients. We identified whether factors influencing cause specific survival in adolescents and young adults (ages 15 to 39) differed from older adults, and defined prognostic factors specifically in adolescents and young adults using the California Cancer Registry. MATERIALS AND METHODS:Patients diagnosed with bladder cancer between 1988 through 2012 were included in the study. The primary outcome measure was cause specific survival. A multivariable Cox proportional hazards regression model was used to evaluate predictors of cause specific survival in patients of all ages and in adolescents/young adults. Interactions of age and other variables between younger and older adult patients were assessed. RESULTS: Of 104,974 patients with bladder cancer we identified 1,688 adolescent and young adult patients (1.6%). Compared to older patients these patients had a 58% reduced risk of bladder cancer death (HR 0.42, p <0.001). Significant age interactions were identified involving race/ethnicity and histology. Among adolescents and young adults, nonHispanic African-American patients with low socioeconomic status had poor cause specific (HR 7.1, p <0.001) and overall (HR 5.02, p <0.001) survival. CONCLUSIONS: Racial/ethnic and socioeconomic disparities exist in adolescent and young adult patients with bladder cancer in California. Further studies are warranted to identify the underlying causes in order to overcome these disparities.
Authors: Matthew E Nielsen; Angela B Smith; Anne-Marie Meyer; Tzy-Mey Kuo; Seth Tyree; William Y Kim; Matthew I Milowsky; Raj S Pruthi; Robert C Millikan Journal: Cancer Date: 2013-10-10 Impact factor: 6.860
Authors: Scarlett Lin Gomez; Salma Shariff-Marco; Mindy DeRouen; Theresa H M Keegan; Irene H Yen; Mahasin Mujahid; William A Satariano; Sally L Glaser Journal: Cancer Date: 2015-04-06 Impact factor: 6.860
Authors: Bruce L Jacobs; Jeffrey S Montgomery; Yun Zhang; Ted A Skolarus; Alon Z Weizer; Brent K Hollenbeck Journal: Urol Oncol Date: 2011-11-27 Impact factor: 3.498
Authors: Elizabeth A Guancial; Breton Roussel; Derek P Bergsma; Kevin C Bylund; Deepak Sahasrabudhe; Edward Messing; Supriya G Mohile; Chunkit Fung Journal: Clin Interv Aging Date: 2015-06-10 Impact factor: 4.458
Authors: Alex W K Wong; Ting-Ting Chang; Katrina Christopher; Stephen C L Lau; Lynda K Beaupin; Brad Love; Kim L Lipsey; Michael Feuerstein Journal: J Cancer Surviv Date: 2017-03-29 Impact factor: 4.442
Authors: Amy M Berkman; Clark R Andersen; Vidya Puthenpura; J A Livingston; Sairah Ahmed; Branko Cuglievan; Michelle A T Hildebrandt; Michael E Roth Journal: Cancer Epidemiol Date: 2021-09-28 Impact factor: 2.984
Authors: Jose M Martinez-Thomas; Luis F Galicia-Belaunzaran; Claudio E Merayo-Chalico; Joseph Palatchi; Juan Carlos Angulo-Lozano Journal: Cureus Date: 2022-05-14
Authors: Amy M Berkman; Clark R Andersen; Branko Cuglievan; David C McCall; Philip J Lupo; Susan K Parsons; Courtney D DiNardo; Nicholas J Short; Nitin Jain; Tapan M Kadia; J A Livingston; Michael E Roth Journal: Cancer Epidemiol Biomarkers Prev Date: 2022-06-01 Impact factor: 4.090
Authors: Claire M de la Calle; Samuel L Washington; Peter E Lonergan; Maxwell V Meng; Sima P Porten Journal: World J Urol Date: 2020-07-31 Impact factor: 4.226
Authors: Murat Akand; Tim Muilwijk; Jan Cornelissen; Siska Van Bruwaene; Kathy Vander Eeckt; Frederic Baekelandt; Pieter Mattelaer; Raf Van Reusel; Ben Van Cleynenbreugel; Steven Joniau; Frank Van Der Aa Journal: Front Oncol Date: 2019-12-11 Impact factor: 6.244
Authors: Florian Janisch; Hang Yu; Malte W Vetterlein; Roland Dahlem; Oliver Engel; Margit Fisch; Shahrokh F Shariat; Armin Soave; Michael Rink Journal: J Clin Med Date: 2019-09-13 Impact factor: 4.241